Blood Plasma IgG Fc Glycans are Significantly Altered in Alzheimer's Disease and Progressive Mild Cognitive Impairment

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2013-11-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.3233/JAD-131088PMID 24028868
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In Silico Instrumental Response Correction Improves Precision of Label-free Proteomics and Accuracy of Proteomics-based Predictive Models*

  2013cited by this paper
• Novel roles for the IgG Fc glycan

  2012cited by this paper
• Immunoglobulin G Fc receptor deficiency prevents Alzheimer-like pathology and cognitive impairment in mice.

  2012cited by this paper
• Human IgG Fc-glycosylation profiling reveals associations with age, sex, female sex hormones and thyroid cancer.

  2012cited by this paper
• CD22 and Siglec-G in B cell function and tolerance.

  2012cited by this paper
• Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's disease

  2012cited by this paper
• Blood-based protein biomarkers for diagnosis of Alzheimer disease.

  2012cited by this paper
• Lipid mediator profiling in pulmonary disease.

  2011cited by this paper
• Alzheimer's Disease and Mild Cognitive Impairment are Associated with Elevated Levels of Isoaspartyl Residues in Blood Plasma Proteins

  2011cited by this paper
• High Throughput Isolation and Glycosylation Analysis of IgG–Variability and Heritability of the IgG Glycome in Three Isolated Human Populations

  2011cited by this paper
• Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid.

  2010cited by this paper
• Differences in Cortical Thickness in Healthy Controls, Subjects with Mild Cognitive Impairment, and Alzheimer's Disease Patients: A Longitudinal Study

  2010cited by this paper
• IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes.

  2010cited by this paper
• Characterizing protein glycosylation sites through higher-energy C-trap dissociation.

  2010cited by this paper
• SYSTEMIC INFLAMMATION AND DISEASE PROGRESSION IN ALZHEIMER DISEASE

  2010cited by this paper
• Complement: a key system for immune surveillance and homeostasis

  2010cited by this paper
• Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action.

  2009cited by this paper
• Implication of Complement System and its Regulators in Alzheimer’s Disease

  2009cited by this paper
• Classification and basic pathology of Alzheimer disease

  2009cited by this paper
• Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.

  2009cited by this paper
• Glycosylation as a strategy to improve antibody-based therapeutics

  2009cited by this paper
• Systemic inflammation and disease progression in Alzheimer disease

  2009cited by this paper
• Anti-RAGE and Abeta immunoglobulin levels are related to dementia level and cognitive performance.

  2009cited by this paper
• Clearance of amyloid-β peptide across the blood-brain barrier: Implication for therapies in Alzheimer’s disease

  2009cited by this paper
• Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry.

  2008cited by this paper
• HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software.

  2008cited by this paper
• Active and passive immunotherapy for neurodegenerative disorders.

  2008cited by this paper
• Deglycosylated anti‐amyloid beta antibodies reduce microglial phagocytosis and cytokine production while retaining the capacity to induce amyloid beta sequestration

  2007cited by this paper
• Chemometrics in metabonomics.

  2007cited by this paper
• Fc-receptors as regulators of immunity.

  2007cited by this paper
• Mannan binding lectin and its interaction with immunoglobulins in health and in disease.

  2006cited by this paper
• Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

  2006cited by this paper
• Identification of B cell adaptor for PI3‐kinase (BCAP) as an Abl interactor 1‐regulated substrate of Abl kinases

  2005cited by this paper
• Complementary structural information from a tryptic N-linked glycopeptide via electron transfer ion/ion reactions and collision-induced dissociation.

  2005cited by this paper
• Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity.

  2003cited by this paper
• Relationship between testosterone, sex hormone binding globulin and plasma amyloid beta peptide 40 in older men with subjective memory loss or dementia

  2003cited by this paper
• RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain

  2003cited by this paper
• Amyloid-beta immunization effectively reduces amyloid deposition in FcRgamma-/- knock-out mice.

  2003cited by this paper
• Amyloid-β Immunization Effectively Reduces Amyloid Deposition in FcRγ-/- Knock-Out Mice

  2003cited by this paper
• Peripheral inflammatory response in Alzheimer's disease and multiinfarct dementia.

  2002cited by this paper
• Reduced cerebrospinal fluid estradiol levels are associated with increased beta-amyloid levels in female patients with Alzheimer's disease.

  2001cited by this paper
• DNA sequence variability of IGHG3 alleles associated to the main G3m haplotypes in human populations

  2001cited by this paper
• Inflammation and Alzheimer's disease.

  2000cited by this paper
• Alpha-1-acid glycoprotein.

  2000cited by this paper
• Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

  2000cited by this paper
• A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.

  2000cited by this paper
• A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.

  2000cited by this paper
• The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms.

  2000cited by this paper
• Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

  2000cited by this paper
• Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

  2000cited by this paper
• Attractin (DPPT-L), a member of the CUB family of cell adhesion and guidance proteins, is secreted by activated human T lymphocytes and modulates immune cell interactions.

  1998cited by this paper
• A detailed lectin analysis of IgG glycosylation, demonstrating disease specific changes in terminal galactose and N-acetylglucosamine.

  1997cited by this paper
• Glycosylation and Placental Transport of Immunoglobulin G

  1996cited by this paper
• A comparative analysis of disease-associated changes in the galactosylation of serum IgG.

  1989cited by this paper
• Sequence of a human immunoglobulin gamma 3 heavy chain constant region gene: comparison with the other human C gamma genes.

  1986cited by this paper
• Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG

  1985cited by this paper
• Human IgG subclasses in health and disease (A review)Part I

  1980cited by this paper

• Immune-Cognitive Relationships Across Viral Infections: A Transnosological Systematic Review.

  2026cites this paper
• A 2-year calorie restriction intervention may reduce glycomic biological age biomarkers – a pilot study

  2025cites this paper
• Soluble Factors and Mechanisms Regulated by Sialylated IgG Signaling

  2025cites this paper
• Serum N-Glycan Profiling Identifies Candidate Glycan Biomarkers for Early Detection and Prediction of Alzheimer's Disease.

  2025cites this paper
• Glycosylation in neuroinflammation: mechanisms, implications, and therapeutic strategies for neurodegenerative diseases

  2025cites this paper
• Recent progress in histone post-translational modifications as regulator of metabolic diseases: A review.

  2025cites this paper
• Mapping the GALNT1 substrate landscape with versatile proteomics tools

  2024cites this paper
• A 2-year calorie restriction intervention reduces glycomic biological age biomarkers

  2024cites this paper
• Immunoglobulin G glycosylation and its alterations in aging-related diseases

  2024cites this paper
• Differential expression of N‐glycopeptides derived from serum glycoproteins in mild cognitive impairment (MCI) patients

  2024cites this paper
• Thiol-ene-based microfluidic chips for glycopeptide enrichment and online digestion of inflammation-related proteins osteopontin and immunoglobulin G

  2023cites this paper
• Fc N‐glycosylation of autoreactive Aβ antibodies as a blood‐based biomarker for Alzheimer's disease

  2023cites this paper
• IgG glycans in health and disease: Prediction, intervention, prognosis, and therapy.

  2023cites this paper
• SpotLight Proteomics Identifies Variable Sequences of Blood Antibodies Specific Against Deamidated Human Serum Albumin

  2023cites this paper
• The sweet side of sex as a biological variable.

  2023cites this paper
• Brain N-Glycosylation and Lipidomic Profile Changes Induced by a High-Fat Diet in Dyslipidemic Hamsters

  2023cites this paper
• Immunoglobulin G glycans - biomarkers and molecular effectors of aging.

  2022cites this paper
• LC-MS/MS Isomeric Profiling of N-Glycans Derived from Low-Abundant Serum Glycoproteins in Mild Cognitive Impairment Patients

  2022cites this paper
• Identification and immune characteristics of molecular subtypes related to protein glycosylation in Alzheimer’s disease

  2022cites this paper
• Proteomic Discovery and Validation of Novel Fluid Biomarkers for Improved Patient Selection and Prediction of Clinical Outcomes in Alzheimer’s Disease Patient Cohorts

  2022cites this paper
• A Preliminary Study on Change of Serum Immunoglobulin G Glycosylation in Patients With Migraine

  2022cites this paper
• Integrated Metabolomics and Proteomics Analysis of Urine in a Mouse Model of Posttraumatic Stress Disorder

  2022cites this paper
• Association Between Immunoglobulin G N-glycosylation and Vascular Cognitive Impairment in a Sample With Atherosclerosis: A Case-Control Study

  2022cites this paper
• A Rapidly Aging World in the 21st Century: Hopes from Glycomics and Unraveling the Biomarkers of Aging with the Sugar Code

  2021influential citation
• Association of dementia with immunoglobulin G N-glycans in a Chinese Han Population

  2021cites this paper
• In-depth Site-specific Analysis of N-glycoproteome in Human Cerebrospinal Fluid and Glycosylation Landscape Changes in Alzheimer's Disease

  2021cites this paper
• Sialylated immunoglobulin G: a promising diagnostic and therapeutic strategy for autoimmune diseases

  2021cites this paper
• Quantitative clinical glycomics strategies: A guide for selecting the best analysis approach.

  2021cites this paper
• Investigation of the causal relationships between human IgG N-glycosylation and twelve common diseases associated with changes in the IgG N-glycome.

  2021cites this paper
• The Rapidly Expanding Nexus of Immunoglobulin G N-Glycomics, Suboptimal Health Status, and Precision Medicine.

  2021cites this paper
• Implications of Glycosylation in Alzheimer’s Disease

  2021cites this paper
• Association of dementia with immunoglobulin G N-glycans in a Chinese Han Population

  2021cites this paper
• Immunoglobulin G Glycosylation in Diseases.

  2021cites this paper
• Immunoglobulin G Glycosylation Changes in Aging and Other Inflammatory Conditions.

  2021cites this paper
• Immunoglobulin Glycosylation – An Unexploited Potential for Immunomodulatory Strategies in Farm Animals

  2021cites this paper
• Profile of Immunoglobulin G N-Glycome in COVID-19 Patients: A Case-Control Study

  2021cites this paper
• Glycosylation Biomarkers Associated with Age-Related Diseases and Current Methods for Glycan Analysis

  2021influential citation
• A comprehensive analysis of subclass-specific IgG glycosylation in colorectal cancer progression by nanoLC-MS/MS.

  2020cites this paper
• Fluid Biomarkers and APOE Status of Early Onset Alzheimer’s Disease Variants: A Systematic Review and Meta-Analysis

  2020cites this paper
• Profiling of IgG N-glycome during mouse aging: Fucosylated diantennary glycans containing one Neu5Gc-linked LacNAc are highly associated with age.

  2020cites this paper
• N-glycomic Profile in Combat Related Post-Traumatic Stress Disorder

  2019cites this paper
• Metabolomic and glycomic findings in posttraumatic stress disorder

  2019cites this paper
• Omics-based biomarkers for the early Alzheimer Disease diagnosis and reliable therapeutic targets development.

  2019influential citation
• IgG Fc N-glycosylation: Alterations in neurologic diseases and potential therapeutic target?

  2019cites this paper
• Increased central adiposity is associated with pro-inflammatory immunoglobulin G N-glycans.

  2019cites this paper
• SpotLight Proteomics—A IgG-Enrichment Phenotype Profiling Approach with Clinical Implications

  2019cites this paper
• Early Stage Glycosylation Biomarkers in Alzheimer’s Disease

  2019influential citation
• Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies

  2018cites this paper
• Immunoglobulin G glycosylation in aging and diseases.

  2018cites this paper
• IgG N-glycans as potential biomarker of chronological and biological ages : A community-based study in a Han Chinese population

  2018cites this paper
• Altered Fc galactosylation in IgG4 is a potential serum marker for chronic lung disease

  2018cites this paper
• Antibody glycosylation in inflammation, disease and vaccination

  2018cites this paper
• Small molecule biomarkers in Alzheimer’s disease

  2018influential citation
• Identification and characterization of antibodies elicited by human cystatin C fragment

  2018cites this paper
• Unravelling Immunoglobulin G Fc N-Glycosylation: A Dynamic Marker Potentiating Predictive, Preventive and Personalised Medicine

  2018cites this paper
• Changes of immunoglobulin G glycosylation with age

  2018cites this paper
• Alteration of Serum IgG Galactosylation as a Potential Biomarker for Diagnosis of Neuroblastoma

  2018cites this paper
• Variable domain N‐linked glycosylation and negative surface charge are key features of monoclonal ACPA: Implications for B‐cell selection

  2018cites this paper
• IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis

  2017cites this paper
• SpotLight Proteomics: uncovering the hidden blood proteome improves diagnostic power of proteomics

  2017cites this paper
• IgG subclass and vaccination stimulus determine changes in antigen specific antibody glycosylation in mice

  2017cites this paper
• Immunoglobulin G N-Glycans as Potential Postgenomic Biomarkers for Hypertension in the Kazakh Population

  2017cites this paper
• Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.

  2017cites this paper
• Recent Advances in the Analysis of Complex Glycoproteins.

  2017cites this paper
• LW-AFC Effects on N-glycan Profile in Senescence-Accelerated Mouse Prone 8 Strain, a Mouse Model of Alzheimer’s Disease

  2017cites this paper
• Proteomic and metabolomic approaches in inflammatory lung diseases

  2017cites this paper
• The N-glycosylation of immunoglobulin G as a novel biomarker of Parkinson's disease

  2017influential citation
• Translational Glycobiology The N -glycosylation of immunoglobulin G as a novel biomarker of Parkinson ’ s disease

  2017cites this paper
• Gender proteomics I. Which proteins in non-sexual organs.

  2017cites this paper
• Profiling IgG N-glycans as potential biomarker of chronological and biological ages

  2016cites this paper
• The Association Between Glycosylation of Immunoglobulin G and Hypertension

  2016cites this paper
• A community-based study in a Han Chinese population

  2016cites this paper
• Studying the Interactions Between Tau, Amyloid, and α-Synuclein in Alzheimer’s Disease Animal and Human Cell Models

  2016cites this paper
• Systemic inflammation, mild cognitive impairment and Alzheimer’s disease: findings from the PREVENT study

  2016cites this paper
• Studies on the role of anti-citrullinated protein antibodies in rheumatoid arthritis

  2016cites this paper
• Isolation and characterization of autoantibodies against human cystatin C

  2016cites this paper
• Metabolic Topology of Neurodegenerative Disorders: Influence of Cognitive and Motor Deficits

  2015cites this paper
• Biomarkers of Alzheimer's Disease

  2015cites this paper
• Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype.

  2015cites this paper
• Intravenous immunoglobulins for Alzheimer's disease.

  2014cites this paper
• IgG Antibodies to Cyclic Citrullinated Peptides Exhibit Profiles Specific in Terms of IgG Subclasses, Fc-Glycans and a Fab-Peptide Sequence

  2014influential citation
• Strategy integrating stepped fragmentation and glycan diagnostic ion-based spectrum refinement for the identification of core fucosylated glycoproteome using mass spectrometry.

  2014cites this paper
• The critical need for defining preclinical biomarkers in Alzheimer's disease

  2014cites this paper
• Recent advances in mass spectrometry-based glycoproteomics.

  2014cites this paper
• Prognostic Polypeptide Blood Plasma Biomarkers of Alzheimer's Disease Progression

  2014cites this paper
• Regulation and Programming of Antibody Effector Function through IgG Glycosylation

  2014cites this paper
• Edinburgh Research Explorer The Association Between Glycosylation of Immunoglobulin G and Hypertension

  year unknowncites this paper
• The association between glycosylation of immunoglobulin G and The association between glycosylation of immunoglobulin G and hypertension: A multiple ethnic cross-sectional study hypertension: A multiple ethnic cross-sectional study

  year unknowncites this paper